Published :
Tables : 48
Figures : 45
Category : Healthcare
No. of Pages : 225
Report Code : HC-1004
Pre-Filled Auto Injectors Market Introduction Pre-filled auto-injectors are defined as unit dose medication for parenteral administration. Pre-filled auto-injectors are intended for self-administration by patients. Pre-filled auto-injectors are mostly spring-loaded syringes and typically made of glass. Pre-filled autoinjectors are used for intramuscular administration of medication with a high degree of dispersion. Pre-filled auto-injector offers varying needle length, spring force & needle gauge. Pre-Filled Auto-Injectors market offers a convenient alternative to traditional subcutaneous injections. It increases patient compliance and adherence during the treatment of various indications. The advantages of pre-filled auto-injectors over the traditional injections have boosted the growth of the market. Further, technological advancements have led to the development of fully automatic injectors with higher patient convenience. Pre-filled auto-injectors are proven reliable, safe and decrease the dose errors. Along with this, changing regulations to control the dose errors have to lead to the rapid growth of pre-filled auto-injectors market. Additionally, they have a wide range of applications in treating autoimmune disorders which further boosted the burgeoning growth of pre-filled auto-injectors market. Other factors like changing socio-demographics and increasing awareness among the general population have created the potential growth of global pre-filled auto-injectors market. North America Pre-Filled Auto-Injectors market is a major shareholder in the global market due to high penetration among the general population. Europe & Asia Pacific regions are expected to witness the highest growth rate in global pre-filled auto-injectors. Latin America and Rest of world Pre-Filled Auto-Injectors markets are expected to account small share in global Pre-Filled Auto-Injectors market due to less adoption. Pre-Filled Auto-Injectors market players include Mylan N.V., Amedra Pharmaceuticals LLC, Owen Mumford, Ypsomed AG, Antares Pharma, SHL Group, Johnson & Johnson, Becton, Dickinson and Company, Pfizer Inc., Eli Lilly and Company. Manufacturers are majorly focused on investing in R&D to strengthen the product portfolio of the market. Pre-Filled Auto Injectors Market Segmentation: By Product Type Reusable Auto Injectors Single Use Auto-injector By Material Type Glass Plastic By Sales Channel Retail Pharmacies Institutional Distribution Online Pharmacies By Region Europe North America APAC Latin America Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways: Growth prospects SWOT analysis Key trends Key datapoints affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global market on the basis of product type, sales channel and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and overall market To predict market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, and Latin America, Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Pre-filled auto-injectors are defined as unit dose medication for parenteral administration. Pre-filled auto-injectors are intended for self-administration by patients. Pre-filled auto-injectors are mostly spring-loaded syringes and typically made of glass. Pre-filled autoinjectors are used for intramuscular administration of medication with a high degree of dispersion. Pre-filled auto-injector offers varying needle length, spring force & needle gauge.
Pre-Filled Auto-Injectors market offers a convenient alternative to traditional subcutaneous injections. It increases patient compliance and adherence during the treatment of various indications. The advantages of pre-filled auto-injectors over the traditional injections have boosted the growth of the market. Further, technological advancements have led to the development of fully automatic injectors with higher patient convenience. Pre-filled auto-injectors are proven reliable, safe and decrease the dose errors. Along with this, changing regulations to control the dose errors have to lead to the rapid growth of pre-filled auto-injectors market. Additionally, they have a wide range of applications in treating autoimmune disorders which further boosted the burgeoning growth of pre-filled auto-injectors market. Other factors like changing socio-demographics and increasing awareness among the general population have created the potential growth of global pre-filled auto-injectors market.
North America Pre-Filled Auto-Injectors market is a major shareholder in the global market due to high penetration among the general population. Europe & Asia Pacific regions are expected to witness the highest growth rate in global pre-filled auto-injectors. Latin America and Rest of world Pre-Filled Auto-Injectors markets are expected to account small share in global Pre-Filled Auto-Injectors market due to less adoption.
Pre-Filled Auto-Injectors market players include Mylan N.V., Amedra Pharmaceuticals LLC, Owen Mumford, Ypsomed AG, Antares Pharma, SHL Group, Johnson & Johnson, Becton, Dickinson and Company, Pfizer Inc., Eli Lilly and Company. Manufacturers are majorly focused on investing in R&D to strengthen the product portfolio of the market.
Pre-Filled Auto Injectors Market Segmentation:
By Product Type
By Material Type
By Sales Channel
By Region
Competitive Landscape:
FutureWise Takeaways:
Objectives of the Study:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Pre-Filled Auto Injectors Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Pre-Filled Auto Injectors Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Pre-Filled Auto Injectors Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Pre-Filled Auto Injectors Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Reusable Auto Injectors 7.2. Single Use Auto-injector 8. Pre-Filled Auto Injectors Market, By Material Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Glass 8.2. Plastic 9. Pre-Filled Auto Injectors Market, By Sales Channel Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Retail Pharmacies 9.2. Institutional Distribution 9.3. Online Pharmacies 10. North America Pre-Filled Auto Injectors Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Pre-Filled Auto Injectors Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Pre-Filled Auto Injectors Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Pre-Filled Auto Injectors Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Mylan N.V. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Amedra Pharmaceuticals LLC 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Owen Mumford 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Ypsomed AG 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Antares Pharma 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. SHL Group 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Johnson & Johnson 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Becton, Dickinson and Company 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Pfizer Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Eli Lilly and Company 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Pre-Filled Auto Injectors Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Pre-Filled Auto Injectors Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Pre-Filled Auto Injectors Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Pre-Filled Auto Injectors Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Reusable Auto Injectors 7.2. Single Use Auto-injector
8. Pre-Filled Auto Injectors Market, By Material Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Glass 8.2. Plastic
9. Pre-Filled Auto Injectors Market, By Sales Channel Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Retail Pharmacies 9.2. Institutional Distribution 9.3. Online Pharmacies
10. North America Pre-Filled Auto Injectors Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Pre-Filled Auto Injectors Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Pre-Filled Auto Injectors Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Pre-Filled Auto Injectors Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Mylan N.V. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Amedra Pharmaceuticals LLC 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Owen Mumford 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Ypsomed AG 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Antares Pharma 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. SHL Group 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Johnson & Johnson 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Becton, Dickinson and Company 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Pfizer Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Eli Lilly and Company 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics